Endoscopic diagnosis and treatment of precancerous colorectal lesions in patients with inflammatory bowel disease: How does the latest SCENIC international consensus intersect with our clinical practice?

Wu, Dong; Li, Jingnan; Qian, Jiaming

doi:10.1515/jtim-2017-0008

Cited by 10 publications

(6 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…IBD patients have a substantial increased risk of CRC over time estimated nearly 1% per year 27 . The ever-increasing use of higher quality endoscopy technologies including high-definition endoscopy, chromoendoscopy, and image-enhanced endoscopy have enhanced the detection of precancerous visible lesions and therefore increased utilization of endoscopic resection techniques 28 . In this systematic review and meta-analysis, we assessed the feasibility, safety, and long-term outcomes of ESD for neoplastic lesions in IBD patients.…”

Section: Discussionmentioning

confidence: 99%

The Feasibility, Safety, and Long-term Outcomes of Endoscopic Submucosal Dissection for Colorectal Neoplasia in Patients With Inflammatory Bowel Disease

Akiyama

Hamdeh

Sakamoto

et al. 2022

Journal of Clinical Gastroenterology

View full text Add to dashboard Cite

Background: Evidence regarding the utility of endoscopic submucosal dissection (ESD) for neoplasia in patients with inflammatory bowel disease (IBD) is limited. This meta-analysis aims to understand the feasibility, safety, and long-term outcomes of ESD in IBD patients. Methods: Electronic databases were searched for observational and case-controlled studies. Primary endpoints were en bloc resection and margin-negative resection of neoplastic lesions. Secondary endpoints included procedure-related bleeding and perforation, local recurrence, and metachronous neoplasia. Results: We analyzed 25 studies with a total of 585 neoplastic lesions in 552 patients. The rates of en bloc resection and margin-negative resection were 0.88 [95% confidence interval (CI) 0.82-0.92] and 0.78 (95% CI 0.72-0.83), respectively. Meta-regression analysis showed longer disease duration was significantly associated with the higher rate of en bloc resection. The rates of procedure-related bleeding and perforation were 0.080 (95% CI 0.057-0.11) and 0.055 (95% CI 0.038-0.081), respectively. The rates of local recurrence and metachronous neoplasia were 0.008 events/person-year (95% CI 0.002-0.013) and 0.031 event/person-year (95% CI 0.016-0.046), respectively. Meta-analysis of case-controlled studies found no significant differences in the endpoints between IBD patients treated by ESD and those treated by endoscopic mucosal resection, or non-IBD patients treated by ESD. Conclusions: ESD is a feasible and safe procedure to remove neoplastic lesions in IBD patients. Given there is a considerable risk of metachronous neoplasia development, postoperative surveillance colonoscopy with an appropriate consultation with surgeons is essential to monitor not only local recurrence but also neoplastic changes in the remaining colon.

show abstract

Section: Discussionmentioning

confidence: 99%

The Feasibility, Safety, and Long-term Outcomes of Endoscopic Submucosal Dissection for Colorectal Neoplasia in Patients With Inflammatory Bowel Disease

Akiyama

Hamdeh

Sakamoto

et al. 2022

Journal of Clinical Gastroenterology

View full text Add to dashboard Cite

show abstract

“… Study subjects. Patient diagnosis of UC was based on the series of Guidelines for Consensus Opinions on the Diagnosis and Treatment of Inflammatory Bowel Disease published by the Chinese Medical Association [ 10 ]. Intervention measures.…”

Section: Methodsmentioning

confidence: 99%

Efficacy and safety of Chinese patent medicine combined with 5-aminosalicylic acid for patients with ulcerative colitis: A network meta-analysis of randomized controlled trials

Zhang,

Su,

Gao

et al. 2024

Heliyon

View full text Add to dashboard Cite

“…The incidence of complications was significantly lower in the ROSE group, a result possibly associated with the lower number of passes required to obtain sufficient samples. [202122]…”

Section: The Debate Lasted 20 Years: Rapid On-site Evaluation or Not?mentioning

confidence: 99%

Rapid on-site evaluation (ROSE) with EUS-FNA: The ROSE Slooks beautiful

Liu

Sun

2019

Endosc Ultrasound

View full text Add to dashboard Cite

Endoscopic diagnosis and treatment of precancerous colorectal lesions in patients with inflammatory bowel disease: How does the latest SCENIC international consensus intersect with our clinical practice?

Cited by 10 publications

References 12 publications

The Feasibility, Safety, and Long-term Outcomes of Endoscopic Submucosal Dissection for Colorectal Neoplasia in Patients With Inflammatory Bowel Disease

The Feasibility, Safety, and Long-term Outcomes of Endoscopic Submucosal Dissection for Colorectal Neoplasia in Patients With Inflammatory Bowel Disease

Efficacy and safety of Chinese patent medicine combined with 5-aminosalicylic acid for patients with ulcerative colitis: A network meta-analysis of randomized controlled trials

Rapid on-site evaluation (ROSE) with EUS-FNA: The ROSE Slooks beautiful

Contact Info

Product

Resources

About